Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis

Blood

Volumn 87, Issue 10, 1996, Pages 4223-4234

  Furlan, Miha ^a   Robles, Rodolfo ^a   Lämmle, Bernhard ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BARIUM; CADMIUM; CALCIUM; COBALT; COPPER; IODOACETAMIDE; LEUPEPTIN; MAGNESIUM; MANGANESE; NICKEL; PROTEINASE; SERINE PROTEINASE INHIBITOR; STRONTIUM; VON WILLEBRAND FACTOR; ZINC;

AMINO ACID COMPOSITION; AMINO TERMINAL SEQUENCE; ARTICLE; CHELATION; DISULFIDE BOND; ENZYME KINETICS; ENZYME PURIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDROPHOBICITY; PRIORITY JOURNAL; PROTEIN DEGRADATION; VON WILLEBRAND DISEASE;

EID: 0029925856     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.10.4223.bloodjournal87104223     Document Type: Article

References (45)

1. Tsai H-M, Nagel RL, Hatcher VB, Sussman II: Multimeric composition of endothelial cell-derived von Willebrand factor. Blood 73:2074, 1989
2. Zimmerman TS, Dent JA, Ruggeri ZM, Nannini LH: Subunit composition of plasma von Willebrand factor. Cleavage is present in normal individuals, increased in IIA and IIB von Willebrand disease, but minimal in variants with aberrant structure of individual oligomers (types IIC, IID, and IIE). J Clin Invest 77:947, 1986
3. Gralnick HR, Williams SB, McKeown LP, Maisonneuve P, Jenneau C, Sultan Y, Rick ME: In vitro correction of the abnormal multimeric structure of von Willebrand factor in type IIA von Willebrand's disease. Proc Natl Acad Sci USA 82:5968, 1985
4. Levene RB, Booyse FM, Chediak J, Zimmerman TS, Livingston DM, Lynch DC: Expression of abnormal von Willebrand factor by endothelial cells from a patient with type IIA von Willebrand disease. Proc Natl Acad Sci USA 84:6550, 1987
5. Battle J, Lasierra J, Villamor AF, Navarro JL, Pardo A, Campos M, Justiça B, Lopez Fernandez MF: Proteolytic processing of von Willebrand factor subunit: heterogeneity in type-IIA von Willebrand disease. Ann Hematol 68:111, 1994
6. Battle J, Lopez Fernandez MF, Campos M, Justica B, Berges C, Navarro JL, Diaz Cremades JM, Kasper CK, Dent JA, Ruggeri ZM, Zimmerman TS: The heterogeneity of type IIA von Willebrand's disease: Studies with protease inhibitors. Blood 68:1207, 1986
7. Berkowitz SD, Dent J, Roberts J, Fujimura Y, Plow EF, Titani K, Ruggeri ZM, Zimmerman TS: Epitope mapping of the von Willebrand factor subunit distinguishes fragments present in normal and type IIA von Willebrand disease from those generated by plasmin. J Clin Invest 79:524, 1987
8. Dent JA, Galbusera M, Ruggeri ZM: Heterogeneity of plasma von Willebrand factor multimers resulting from proteolysis of the constituent subunit. J Clin Invest 88:774, 1991
9. Furlan M, Robles R, Affolter D, Meyer D, Baillod P, Lämmle B: Triplet structure of von Willebrand factor reflects proteolytic degradation of high molecular weight multimers. Proc Natl Acad Sci USA 90:7503, 1993
10. Battle J, Lopez-Fernandez MF, Lopez-Borrasca A, Lopez-Berges C, Dent JA, Berkowitz SD, Ruggeri ZM, Zimmerman TS: Proteolytic degradation of von Willebrand factor after DDAVP administration in normal individuals. Blood 70:173, 1987
11. Budde U, Dent JA, Berkowitz SD, Ruggeri ZM, Zimmerman TS: Subunit composition of plasma von Willebrand factor in patients with myeloproliferative syndrome. Blood 68:1213, 1986
12. Moake JL, Rudy CK, Troll JH, Weinstein MJ, Colannino NM, Azocar J, Seder RH, Hong SL, Deykin D: Unusually large plasma factor VIII: von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. N Engl J Med 307:1432, 1982
13. Moake JL, Byrnes JJ, Troll JH, Rudy CK, Hong SL, Weinstein MJ, Colannino NM: Effects of fresh-frozen plasma and its cryosupernalant fraction on von Willebrand factor multimeric forms in chronic relapsing thrombotic thrombocytopenic purpura. Blood 65:1232, 1985
14. Andersen JC, Switzer ME, McKee PA: Support of ristocetin-induced platelet aggregation by procoagulant-inactive and plasmin-cleaved forms of human factor VIII/von Willebrand factor. Blood 55:101, 1980
15. Hamilton KK, Fretto LJ, Grierson DS, McKee PA: Effects of plasmin on von Willebrand factor multimers. Degradation in vitro and stimulation of release in vivo. J Clin Invest 76:261, 1985
16. Howard MA, Greco T, Coghlan M: Cleavage of human von Willebrand factor by porcine pancreatic elastase. Blood 74:673, 1989
17. Thompson EA, Howard MA: Proteolytic cleavage of human von Willebrand factor induced by enzyme(s) released from polymorphonuclear cells. Blood 67:1281, 1986
18. Tsai H-M, Nagel RL, Hatcher VB, Sussman II: Endothelial cell-derived high molecular weight von Willebrand factor is converted into the plasma multimer patterns by granulocyte proteases. Biochem Biophys Res Commun 158:980, 1989
19. Berkowitz SD, Nozaki H, Titani K, Murachi T, Plow EF, Zimmerman TS: Evidence that calpains and elastase do not produce the von Willebrand factor fragments present in normal plasma and IIA von Willebrand disease. Blood 72:721, 1988
20. Phillips MD, Vu C, Nolasco L, Moake JL: Granulocyte proteases do not process endothelial cell-derived unusually large von Willebrand factor multimers to plasma vWF in vivo. Am J Hematol 37:80, 1991
21. Kunicki TJ, Montgomery RR, Schullek J: Cleavage of human von Willebrand factor by platelet calcium-activated protease. Blood 65:352, 1985
22. Dent JA, Berkowitz SD, Ware J, Kasper CK, Ruggeri ZM: Identification of a cleavage site directing the immunochemical detection of molecular abnormalities in type IIA von Willebrand factor. Proc Natl Acad Sci USA 87:6306, 1990
23. Marusyk R, Sergeant A: A simple method for dialysis of small-volume samples. Anal Biochem 105:403, 1980
24. Ruggeri ZM, Zimmerman TS: The complex multimeric composition of factor VIII/von Willebrand factor. Blood 57:1140, 1981
25. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage G4. Nature 227:680, 1970
26. Moake JL, Turner NA, Stathopoulos NA, Nolasco LH, Heliums JD: Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation. J Clin Invest 78:1456, 1986
27. Tsai H-M, Sussman II, Nagel RL: Shear stress enhances the proteolysis of von Willebrand factor in normal plasma. Blood 83:2171, 1994
28. van Mourik JA, Bouma BN, LaBruyère WT, de Graaf S, Mochtar IA: Factor VIII, a series of homologous oligomers and a complex of two proteins. Thromb Res 4:155, 1974
29. Bouma BN, van Mourik JA, de Graaf S, Hordijk-Hos JM, Sixma JJ: Immunologic studies on human factor VIII (anti-nemophilic factor A, AHF) components produced by low-ionic-strength dialysis. Blood 47:253, 1976
30. Furlan M, Beck EA: Degradation of purified factor VIII by endogenous contaminating enzymes. Thromb Res 10:153, 1977
31. Hilz H, Fanick W: Divergent denaturation of proteases by urea and dodecylsulfate in the absence of substrate. Hoppe-Seyler Z Physiol Chem 359:1447, 1978
32. Asghar SS, Cormane RH: Some properties of proteolysis by polymorphonuclear leukocyte-granule extracts. J Invest Dermatol 66:93, 1976
33. Hojima Y, Behta B, Romanic AM, Prockop DJ: Cleavage of type I procollagen by C- and N-proteinases is more rapid if the substrate is aggregated with dextran sulfate or polyethylene glycol. Anal Biochem 223:173, 1994
34. Mannucci PM, Lattuada A, Ruggeri ZM: Proteolysis of von Willebrand factor in therapeutic plasma concentrates. Blood 83:3018, 1994
35. Keil-Dlouha V, Planchenault T: Potential proteolytic activity of human fibronectin. Proc Natl Acad Sci USA 83:5377, 1986
36. Lambert Vidmar S, Lottspeich F, Emod I, Planchenault T, Keil-Dlouha V: Latent fibronectin-degrading serine proteinase activity in N-terminal heparin-binding domain of human plasma fibronectin. Eur J Biochem 201:71, 1991
37. Lambert Vidmar S, Lottspeich F, Emod I, Imhoff J-M, Keil-Dlouha V: Collagen-binding domain of human plasma fibronectin contains a latent type-IV collagenase. Eur J Biochem 201:79, 1991
38. Crawford C, Mason RW, Wikstrom P, Shaw E: The design of peptidyldiazomethane inhibitors to distinguish between the cysteine proteinases calpain II, cathepsin L and cathepsin B. Biochem J 253:751, 1988
39. 2M. Thromb Res 16:859, 1979
40. 2-macroglobuHn-enzyme complexes toward human factor VIII/von Willebrand factor. Biochemistry 22:1437, 1983
41. 2-macroglobulin half-molecules with plasmin as a probe of protease binding site structure. Biochemistry 22:4933, 1983
42. 2-macroglobulin subunits. J Biol Chem 254:4452, 1979
43. Hobohm U, Houthaeve T, Sander C: Amino acid analysis and protein database composition search as a fast and inexpensive method to identify proteins. Anal Biochem 222:202, 1994
44. Galanakis DK, Mosesson MW, Stathakis NE: Human fibrinogen heterogeneities: Distribution and charge characteristics of chains of Aa origin. J Lab Clin Med 92:376, 1987
45. Kunicki TJ, Mosesson MW, Pidard D: Cleavage of fibrinogen by human platelet calcium-activated protease. Thromb Res 35:169, 1984